BRISTOL, Tenn., Feb. 21 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company plans to announce financial
results for the fourth quarter and year ending December 31, 2005 prior to the
market open on Tuesday, February 28, 2006. The Company also plans to provide
a live conference call to discuss its financial results beginning at 1:00 p.m.
E.S.T. later that same day. Conference call information will be provided
when available via a subsequent press release.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated date for release of the
Company's financial results for the fourth quarter and year ending December
31, 2005. These forward-looking statements involve certain significant risks
and uncertainties, and actual results may differ materially from the forward-
looking statements. Some important factors which may cause results to differ
include: dependence on King's ability to release the Company's financial
results for fourth quarter and year ending December 31, 2005 as currently
planned on February 28, 2006. Other important factors that may cause actual
results to differ materially from the forward-looking statements are discussed
in the "Risk Factors" section and other sections of King's Form 10-K for the
year ended December 31, 2004 and Form 10-Q for the third quarter ended
September 30, 2005, which are on file with the Securities and Exchange
Commission. King does not undertake to publicly update or revise any of its
forward-looking statements even if experience or future changes show that the
indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
